UBS Group Portfolio holdings
UBS Group AG, formed through the 1998 merger of Union Bank of Switzerland and Swiss Bank Corporation with roots dating back to 1862, is a Swiss multinational investment bank and financial services firm headquartered in Zurich. Renowned for its dominance in wealth management, UBS serves high-net-worth individuals and families globally, managing trillions in assets, while also offering investment banking, asset management, and retail banking services in Switzerland. The firm has weathered significant challenges, including a major bailout during the 2008 financial crisis, but has since refocused on stability and sustainable growth, emphasizing digital transformation and ESG (environmental, social, governance) investing. With a strong European base and a global reach, UBS remains a cornerstone of the international financial landscape.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
NVIDIA
NVDA
|
+$1.12B |
| 2 |
Apple
AAPL
|
+$1.08B |
| 3 |
Microsoft
MSFT
|
+$1.05B |
| 4 |
Nike
NKE
|
+$1.03B |
| 5 |
Alphabet (Google) Class C
GOOG
|
+$821M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
BioMarin Pharmaceuticals
BMRN
|
+$389M |
| 2 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$383M |
| 3 |
iShares 7-10 Year Treasury Bond ETF
IEF
|
+$348M |
| 4 |
PXD
Pioneer Natural Resource Co.
PXD
|
+$263M |
| 5 |
NRG Energy
NRG
|
+$237M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 17.8% |
| 2 | Financials | 8.25% |
| 3 | Healthcare | 6.4% |
| 4 | Consumer Discretionary | 5.85% |
| 5 | Communication Services | 4.91% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
3426
CALL
CGI
GIB
$15.5B
| $2.76M | ﹤0.01% |
27,671
| – | – |
|
3427
iShares MSCI USA Small-Cap Min Vol Factor ETF
SMMV
$291M
| $2.76M | ﹤0.01% |
74,013
-76,664
| -51% | -$2.83M |
|
|
KLG
3428
DELISTED
WK Kellogg Co
KLG
| $2.76M | ﹤0.01% |
167,483
-24,485
| -13% | -$497K |
|
|
NSA
3429
DELISTED
National Storage Affiliates Trust
NSA
| $2.75M | ﹤0.01% |
66,644
-25,473
| -28% | -$960K |
|
3430
PJT Partners
PJT
$4.3B
| $2.75M | ﹤0.01% |
25,457
-11,373
| -31% | -$1.14M |
|
3431
PUT
Bath & Body Works
BBWI
$3.93B
| $2.75M | ﹤0.01% |
70,300
| – | – |
|
3432
PUT
Scotiabank
BNS
$108B
| $2.74M | ﹤0.01% |
60,000
| – | – |
|
|
THW
3433
abrdn World Healthcare Fund
THW
$556M
| $2.74M | ﹤0.01% |
208,541
-2,698
| -1% | -$34.6K |
|
|
FITB
3434
CALL
Fifth Third Bancorp
FITB
$51.7B
| $2.74M | ﹤0.01% |
75,000
-125,000
| -63% | -$4.57M |
|
3435
Trinity Capital Inc.
TRIN
$1.73B
| $2.73M | ﹤0.01% |
193,412
+19,718
| +11% | +$291K |
|
3436
Banco Santander
SAN
$209B
| $2.73M | ﹤0.01% |
590,550
-13,017
| -2% | -$64.1K |
|
3437
Invesco S&P MidCap 400 GARP ETF
GRPM
$509M
| $2.73M | ﹤0.01% |
23,886
-478
| -2% | -$55.4K |
|
3438
PUT
State Street SPDR S&P Homebuilders ETF
XHB
$1.58B
| $2.73M | ﹤0.01% |
+27,000
| New | +$2.82M |
|
3439
Cohen & Steers Closed End Opportunity Fund
FOF
$383M
| $2.73M | ﹤0.01% |
228,051
-2,504
| -1% | -$29.1K |
|
|
MCN
3440
Madison Covered Call & Equity Strategy Fund
MCN
$119M
| $2.72M | ﹤0.01% |
358,356
-40,395
| -10% | -$291K |
|
3441
Genco Shipping & Trading
GNK
$1.09B
| $2.72M | ﹤0.01% |
127,646
-167,275
| -57% | -$3.6M |
|
3442
CALL
Sherwin-Williams
SHW
$88.2B
| $2.72M | ﹤0.01% |
9,100
| – | – |
|
|
3443
PUT
Sherwin-Williams
SHW
$88.2B
| $2.72M | ﹤0.01% |
9,100
| – | – |
|
3444
Cushman & Wakefield Ltd
CWK
$3.12B
| $2.71M | ﹤0.01% |
260,878
+110,589
| +74% | +$1.14M |
|
3445
Ituran Location and Control
ITRN
$1.03B
| $2.71M | ﹤0.01% |
110,022
+35,619
| +48% | +$944K |
|
3446
Rhythm Pharmaceuticals
RYTM
$7.94B
| $2.71M | ﹤0.01% |
65,942
-105,623
| -62% | -$4.22M |
|
3447
CALL
Dover
DOV
$28.3B
| $2.71M | ﹤0.01% |
+15,000
| New | +$2.69M |
|
3448
Floor & Decor
FND
$6.31B
| $2.7M | ﹤0.01% |
27,210
-24,891
| -48% | -$2.86M |
|
3449
A10 Networks
ATEN
$2.08B
| $2.7M | ﹤0.01% |
194,615
+85,283
| +78% | +$1.22M |
|
3450
Vera Therapeutics
VERA
$2.27B
| $2.69M | ﹤0.01% |
74,462
-51,921
| -41% | -$2.06M |
|
Similar funds
UBS Group's Q2 2024 Portfolio in Review
As of Q2 2024, UBS Group held 10,501 positions worth $405B, up 0.81% from $402B the previous quarter. Its ten largest holdings account for 18% of the portfolio.
UBS Group's Q2 2024 filing shows 1,231 new, 3,688 increased, 4,131 reduced and 1,043 closed positions. Its largest new stake was SLB Ltd: 10,925,731 shares worth $515M. The largest sale was BioMarin Pharmaceuticals, an estimated $389M.
By sector, the portfolio is most concentrated in Technology at 18% of assets, up from 15% a quarter earlier, followed by Financials and Healthcare.
- UBS Group's largest Q2 2024 buy was SLB Ltd: 10,925,731 shares worth $515M.
- UBS Group added most to NVIDIA in Q2 2024, an estimated $1.12B increase.
- UBS Group's biggest Q2 2024 reduction was BioMarin Pharmaceuticals, cutting an estimated $389M.
- UBS Group fully exited Pioneer Natural Resource Co. in Q2 2024, selling an estimated $263M.
- UBS Group's ten largest holdings make up 18% of its $405B portfolio in Q2 2024.
- UBS Group opened 1,231 new positions and closed 1,043 in Q2 2024.
- UBS Group's portfolio value rose 0.81% quarter-over-quarter to $405B.
Based on UBS Group's 13F filing for Q2 2024, filed 14 Aug 2024.